| Bassanio Leong, | |
|
300 Pullman St Bldg G, Livermore, CA 94551-9756 | |
| (925) 960-6996 | |
| Not Available |
| Full Name | Bassanio Leong |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 300 Pullman St Bldg G, Livermore, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912438896 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 46341 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bassanio Leong, 300 Pullman St Bldg G, Livermore, CA 94551-9756 Ph: (925) 960-6996 | Bassanio Leong, 300 Pullman St Bldg G, Livermore, CA 94551-9756 Ph: (925) 960-6996 |
News Archive
One of the main indicators for determining the activity of a tumour or cancer is cell division. Cancer cells divide more than other types and the genes and molecules involved in the process of division are, often, targets for identifying and treating certain types of cancer.
Gemin X Pharmaceuticals, a clinical stage biopharmaceutical company developing novel, targeted cancer therapeutics, today announced the completion of patient enrollment in a Phase 2 clinical trial of the Company's lead product candidate obatoclax (GX15-070) for the treatment of extensive-stage small cell lung cancer (SCLC). The trial is designed to evaluate the efficacy and safety of obatoclax, a novel pan Bcl-2 inhibitor, in combination with standard chemotherapy for the first-line treatment of patients with SCLC.
An investigational vaccine designed to protect against the B.1.351 SARS-CoV-2 variant has been administered as part of a new Phase 1 clinical trial evaluating the vaccine candidate's safety and immunogenicity in adult volunteers.
Type 1 diabetes, which usually appears in children and adolescents, affects over 30 million people worldwide. Resulting from an auto-immune reaction that destroys the pancreatic beta cells that produce insulin, the disease leads to pathologically high levels of sugar in the blood and urine, resulting in high rates of morbidity and mortality. The current treatment for Type 1 diabetes is lifetime administration of insulin by injection.
› Verified 6 days ago
Mike Ainsley Ring Jr., PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4300 Las Positas Rd, Livermore, CA 94551 Phone: 925-245-1406 Fax: 925-245-1406 | |
Anne-marie Vo, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pullman St Bldg G, Livermore, CA 94551 Phone: 888-218-6245 | |
Brian Bui, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pullman St Bldg G, Livermore, CA 94551 Phone: 925-960-6996 | |
Miss May Chung, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pullman St, Livermore, CA 94551 Phone: 925-453-3953 | |
Evelyn Chun, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3000 Las Positas Rd, Livermore, CA 94551 Phone: 925-243-4995 | |
Dr. Nick T Truong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 968 Murrieta Blvd, Livermore, CA 94550 Phone: 925-373-0455 | |
Tiffany Lee, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 Pullman St, Livermore, CA 94551 Phone: 925-453-3966 |